IXIGO board meet Oct 17 to approve Sep 2026 results

What the latest BSE filing says

Le Travenues Technology Ltd (IXIGO) has informed the BSE that its Board of Directors will meet on 17 October 2026. The stated agenda includes consideration and approval of the company’s financial results for the quarter and half year ended 30 September 2026. The board-meeting intimation was reported on 12 October 2026 at 06:26 pm, with the source attributed to BSE.

The update is relevant for investors tracking the company’s periodic earnings cycle and the formal approval process required before results are disclosed to the market. Board meeting schedules are also closely watched because they anchor timelines for regulatory filings and investor communication.

Result date: October 17, 2026, and a conflicting calendar note

In the same information flow, an “Upcoming Result” prompt indicates that Le Travenues will declare its result soon on 17 Oct 2026. Separately, the feed also carries a line stating: “The next results date for Le Travenues Technology Ltd is 06 August 2026.”

Both dates appear in the provided material. The October 17 meeting is explicitly tied to approval of results for the quarter and half year ended September 30, 2026. The August 6 date is also referenced elsewhere in the text in relation to financial results for the quarter ended June 30, 2026.

Given the presence of both entries, readers should rely on the most specific disclosure for the relevant period. Here, the 17 October 2026 board meeting is clearly linked to the September 30, 2026 reporting period.

Other disclosures: analyst and investor meet intimation

The “Latest News” list also includes an item dated 12 October 2026 titled: “Announcement under Regulation 30 (LODR) - Analyst / Investor Meet - Intimation.” The provided extract does not include the date, time, or format of the meet, but it indicates the company made a Regulation 30 disclosure related to investor interactions.

For listed companies, such intimation is typically meant to ensure equitable access to information and a clear public trail of scheduled engagements. Investors often track these notices for potential commentary around performance, strategy, and near-term priorities, although the notice itself does not confirm any new financial details.

Earlier board outcome: ESOP-driven equity share allotment

Le Travenues Technology’s filings also reference a board meeting outcome dated 23 July 2026. According to the “Key Developments” portion in the provided text, the board meeting (scheduled at 16:30 IST) was set to consider and approve the allotment of 2,375,151 fully paid equity shares of face value ₹1 each.

The allotment is described as being linked to the exercise of vested employee stock options across multiple ESOP schemes, referenced from 2012 to 2025. While the extract does not specify the post-allotment paid-up capital, the disclosure is important because ESOP allotments can incrementally increase the equity base.

AGM-related corporate action: authorised share capital proposal

Another item in the provided content states that the company planned to seek shareholder approval at its AGM on September 30, 2026. The proposal mentioned is to increase authorised share capital and amend the capital clause of the company’s Memorandum of Association.

This kind of resolution is typically pursued to create headroom for future issuances, which could include ESOP allotments, fundraising, or other corporate actions. The material provided does not include the revised authorised capital figure or the exact resolution wording.

Corporate actions snapshot from the calendar

The corporate actions table in the extract lists multiple meeting dates and purposes. The entries provide a quick view of the company’s recurring result-approval cadence and shareholder meetings.

Analyst target revision noted in the update

The text also states that analysts have revised their price target for Le Travenues Technology to ₹205.89 from ₹224.11. No brokerage name, date of revision, or rationale is provided in the supplied excerpt, but the direction of change is clearly mentioned.

Market impact: what is known from the disclosed facts

From the information provided, the immediate market-relevant trigger is the scheduled 17 October 2026 board meeting for approval of results for the quarter and half year ended 30 September 2026. Such events typically heighten investor attention because they set the window for official financial disclosures and management commentary.

Separately, the ESOP allotment of 2,375,151 equity shares (face value ₹1) is a concrete corporate action disclosed in the update. While the excerpt does not quantify dilution in percentage terms, the issuance adds to the number of outstanding shares.

The analyst target revision to ₹205.89 from ₹224.11 is another factual marker in the feed, indicating that at least one tracked consensus update moved lower. However, the provided material does not include any contemporaneous share-price move, volume, or index impact.

Why this board meeting matters in the reporting cycle

Board meeting intimations are a core part of listed-company disclosure in India, especially around financial results. The specific mention of both the quarter and the half year ended September 30, 2026 indicates the company will be placing a broader performance set before the board, not only a single quarter.

The surrounding disclosures in the same period also show an active corporate calendar: an AGM with a proposal related to authorised share capital, and an ESOP-related allotment. Taken together, these filings suggest the company is managing both periodic reporting obligations and equity-related actions through formal board and shareholder processes.

Conclusion

Le Travenues Technology (IXIGO) has scheduled a board meeting on 17 October 2026 to consider and approve financial results for the quarter and half year ended 30 September 2026, as per its BSE intimation. Recent updates also include an ESOP-related allotment of 2,375,151 equity shares and an AGM proposal related to authorised share capital. The next confirmed step, based on the disclosure, is the board’s consideration of the September-period results on October 17.